Non-invasive Prediction of EArly Cardiac rEjection
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT07770659
- Status
- Recruiting
Conditions
- Cardiac MRI
- Cell Free DNA
- Heart Transplant
- Pediatric Heart Transplant
- Rejection
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 25 Years
- Healthy Volunteers
- Not accepted
Study Details
Acute rejection remains a major cause of morbidity and mortality in pediatric patients after heart transplant. In order to screen for rejection, most centers perform heart catheterizations with endomyocardial biopsies frequently in the first year post transplant and then every 1-2 years thereafter; these biopsies are associated with complications, can cause significant anxiety in patients and family members, and are a significant cost for the healthcare system. This project will evaluate non-invasive methods of detecting rejection using cardiac magnetic resonance imaging and blood testing with a goal to reduce the required number of cardiac catheterizations.
Key Dates
- First listed
- Aug 18, 2026
- Start date
- Mar 29, 2023
- Status verified
- Jun 2026
- Primary completion
- Feb 1, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Healthy pediatric heart transplant recipientsPediatric heart transplant recipients not having rejection
- Arm: Pediatric heart transplant recipients with acute rejectionPediatric heart transplant recipients with acute rejection (ACR or AMR) as defined by the the core pathologist.
- Arm: Healthy controlsHealthy control patients retrospectively enrolled at each site to standardize parametric mapping.
Primary Outcome Measure
Acute rejection [ Time Frame: time of enrollment ]
Central Contacts
- Jonathan Soslow, MD MSCI615-322-7447
Locations (22)
Find similar trials in Little Rock, AR
Related Studies
- Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies TrialEnrolling By Invitation · Indiana University · Indianapolis, Indiana
- Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant RecipientsRecruiting · University of Florida · Coral Gables, Florida
- US National OCS Heart Perfusion (OHP) RegistryRecruiting · TransMedics · Phoenix, Arizona
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac RehabilitationRecruiting · University of California, San Francisco · San Francisco, California